Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 823,572	$ 746,724
Trade accounts receivable, less allowance for doubtful accounts (2021 – $2,623; 2020 – $2,083)	455,222	530,838
Other accounts receivable	58,256	61,958
Inventories	732,563	750,237
Other current assets	81,741	116,427
Total current assets	2,151,354	2,206,184
Property, plant and equipment, at cost	7,596,684	7,427,641
Less accumulated depreciation and amortization	2,086,085	2,073,016
Net property, plant and equipment	5,510,599	5,354,625
Investments	907,080	656,244
Other assets	256,081	219,268
Goodwill	1,640,720	1,665,520
Other intangibles, net of amortization	331,092	349,105
Total assets	10,796,926	10,450,946
Current liabilities:
Accounts payable	535,153	483,221
Accrued expenses	317,954	440,763
Current portion of long-term debt	623	804,677
Dividends payable	45,428	40,937
Income taxes payable	85,770	32,251
Total current liabilities	984,928	1,801,849
Long-term debt	2,043,794	2,767,381
Postretirement benefits	47,371	48,075
Pension benefits	309,712	340,818
Other noncurrent liabilities	616,912	629,377
Deferred income taxes	428,438	394,852
Commitments and contingencies (Note 9)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 116,945 in 2021 and 106,842 in 2020	1,169	1,069
Additional paid-in capital	2,907,981	1,438,038
Accumulated other comprehensive loss	(328,001)	(326,132)
Retained earnings	3,584,400	3,155,252
Total Albemarle Corporation shareholders’ equity	6,165,549	4,268,227
Noncontrolling interests	200,222	200,367
Total equity	6,365,771	4,468,594
Total liabilities and equity	$ 10,796,926	$ 10,450,946